Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo

Signal Transducer and Activator of Transcription-3 (STAT3) is constitutively activated in many cancers where it promotes growth, inflammation, angiogenesis and inhibits apoptosis. We have shown that STAT3 is constitutively activated in human gastric cancer, and that chronic IL-11-driven STAT3 transcriptional activity induces gastric tumourigenesis in the gp130757FF mouse model of gastric cancer development. Here we show that treatment of human AGS gastric cancer cells with the Janus Kinase (JAK) inhibitor WP1066 dose-, and time-dependently inhibits STAT3 phosphorylation, in conjunction with reduced JAK2 phosphorylation, reduced proliferation and increased apoptosis. In addition, application of intraperitoneal WP1066 for 2 weeks, reduced gastric tumour volume by 50% in the gp130757FF mouse coincident with reduced JAK2 and STAT3 activation compared with vehicle-treated, littermate controls. Gastric tumours from WP1066- treated mice had reduced polymorphonuclear inflammation, coincident with inhibition of numerous proinflammatory cytokines including IL-11, IL-6 and IL-1β, as well as the growth factors Reg1 and amphiregulin. These results show that WP1066 can block proliferation, reduce inflammation and induce apoptosis in gastric tumour cells by inhibiting STAT3 phosphorylation, and that many cytokines and growth factors that promote gastric tumour growth are regulated by STAT3-dependent mechanisms. WP1066 may form the basis for future therapeutics against gastric cancer.

[1]  Jie Hong,et al.  A positive feedback loop between STAT3 and cyclooxygenase‐2 gene may contribute to Helicobacter pylori‐associated human gastric tumorigenesis , 2014, International journal of cancer.

[2]  S. Weiss,et al.  On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. , 2013, Neuro-oncology.

[3]  Diego Miranda-Saavedra,et al.  Distinct transcriptional regulatory modules underlie STAT3’s cell type-independent and cell type-specific functions , 2013, Nucleic acids research.

[4]  Alexander Hapfelmeier,et al.  Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines. , 2012, International journal of oncology.

[5]  G. Fuller,et al.  The tumor microenvironment expression of p‐STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models , 2012, International journal of cancer.

[6]  M. Hatakeyama,et al.  Helicobacter pylori CagA Triggers Expression of the Bactericidal Lectin REG3γ via Gastric STAT3 Activation , 2012, PloS one.

[7]  K. Aldape,et al.  Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway , 2012, Journal of Neuro-Oncology.

[8]  A. Giraud,et al.  IL-11 is a parietal cell cytokine that induces atrophic gastritis , 2011, Gut.

[9]  M. Lamkanfi,et al.  The Nlrp3 inflammasome: contributions to intestinal homeostasis. , 2011, Trends in immunology.

[10]  T. Ishikawa,et al.  Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis , 2011, Cancer science.

[11]  W. Priebe,et al.  Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia , 2010, Leukemia.

[12]  A. Horiguchi,et al.  STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma , 2010, British Journal of Cancer.

[13]  F. Ali-Osman,et al.  Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes , 2010, Molecular Cancer Research.

[14]  Hiroko Oshima,et al.  The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. , 2009, Gastroenterology.

[15]  G. Bhagat,et al.  Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. , 2008, Cancer cell.

[16]  G. Fuller,et al.  A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells , 2008, Clinical Cancer Research.

[17]  J. Karras,et al.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, Journal of Clinical Investigation.

[18]  Z. Estrov,et al.  WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F Mutation , 2008, Clinical Cancer Research.

[19]  Z. Estrov,et al.  WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. , 2007, Cancer research.

[20]  A. Boussioutas,et al.  Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression , 2007, The Journal of pathology.

[21]  K. Hess,et al.  A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo , 2007, Oncogene.

[22]  T. Wang,et al.  Gene expression profiling in a mouse model of Helicobacter‐induced gastric cancer , 2007, Cancer science.

[23]  T. Nakayama,et al.  Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. , 2007, International journal of oncology.

[24]  Feng-Lin Chen,et al.  12-Lipoxygenase Induces Apoptosis of Human Gastric Cancer AGS Cells via the ERK1/2 Signal Pathway , 2007, Digestive Diseases and Sciences.

[25]  B. Jenkins,et al.  STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. , 2006, Gastroenterology.

[26]  T. Tsukamoto,et al.  Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. , 2006, Gastroenterology.

[27]  N. L. La Gruta,et al.  Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. , 2005, Gastroenterology.

[28]  S. Takasawa,et al.  REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. , 2005, Gastroenterology.

[29]  K. Aldape,et al.  Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer , 2005, Clinical Cancer Research.

[30]  H. Seno,et al.  STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells , 2004, Oncogene.

[31]  Hiroko Oshima,et al.  Hyperplastic gastric tumors induced by activated macrophages in COX‐2/mPGES‐1 transgenic mice , 2004, The EMBO journal.

[32]  W. An,et al.  ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells , 2004, Cell Research.

[33]  B. Jenkins,et al.  Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. , 2004, Gastroenterology.

[34]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[35]  J. Turkson,et al.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. , 2003, Cancer research.

[36]  T. Hirano,et al.  IL-6 signal transduction and its physiological roles: the signal orchestration model. , 2003, Reviews of physiology, biochemistry and pharmacology.

[37]  J. Pow-Sang,et al.  Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. , 2002, Cancer research.

[38]  B. Jenkins,et al.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice , 2002, Nature Medicine.

[39]  Jiayuh Lin,et al.  Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells , 2001, Oncogene.

[40]  R. Jove,et al.  Prostate adenocarcinoma: cellular and molecular abnormalities. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[41]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[42]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[43]  J. Turkson,et al.  Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation , 1998, Molecular and Cellular Biology.

[44]  T. Hirano,et al.  Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein* , 1998, The Journal of Biological Chemistry.

[45]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human gastric carcinoma. , 1997, Cancer research.

[46]  V. Poli,et al.  Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans , 1996, The Journal of experimental medicine.

[47]  K. Yasukawa,et al.  Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. , 1994, Experimental hematology.

[48]  N. Normanno,et al.  Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Coffey,et al.  Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. , 1992, Cancer research.